NextGenDoes three targets mean the right choice for me?
The count describes a compound's design. It cannot settle a personal care decision. Retatrutide's three targets do not change its trial-only status.
ONE, TWO, THREE TARGETS
NextGen Peptides, explained.
Searching for NextGen Peptides retatrutide? Compare three peptide generations. Retatrutide is in clinical trials: studies in people. Semaglutide and tirzepatide have prescription products.
Retatrutide is not approved by the U.S. Food and Drug Administration (FDA) and is not available by prescription.
THE GENERATION LADDER
01 — 03
- 01
Semaglutide
GLP-1
FDA-approved products exist. Compounded versions are not FDA-approved.
- 02
Tirzepatide
GIP + GLP-1
FDA-approved products exist. Compounded versions are not FDA-approved.
- 03
Retatrutide
GLP-1 + GIP + glucagon
Investigational · in trials
01
The number describes the targets.
A peptide is a short chain of protein building blocks. A receptor is a part of a cell that receives a signal. Here, a generation means the number of receptor types a compound acts on. It is a way to read the science, not a score for choosing care.
- 01
Semaglutide
One receptor target: GLP-1. FDA-approved products exist; compounded semaglutide is not FDA-approved.
Read about semaglutide - 02
Tirzepatide
Two receptor targets: GIP and GLP-1. FDA-approved products exist; compounded tirzepatide is not FDA-approved.
Read about tirzepatide - 03
Retatrutide
Three receptor targets: GLP-1, GIP and glucagon. Investigational, not FDA-approved and not available by prescription.
Read about retatrutide
02
Two names in prescription care. One still in trials.
FDA-approved products containing semaglutide and tirzepatide exist. FDA is short for the U.S. Food and Drug Administration. Approval belongs to a specific medicine, not to every product that uses its ingredient name.
Compounding means making a medicine to order. Compounded semaglutide and compounded tirzepatide are not FDA-approved. A licensed provider decides whether a medicine is appropriate; legal limits also apply to compounding.
Retatrutide is investigational, meaning it is still being studied. It is in Phase 3 clinical trials, which are studies in people. Trial status does not make it a prescription option.
03
A research label leaves a gap in care.
The FDA warns that products sold for research purposes can be of unknown quality and may be harmful. Retatrutide offered online is not a substitute for the conditions of a clinical trial.
An online research order
Some products are sold with labels such as “not for human use.” An order is not a health review. No licensed provider is assessing your health as part of that research-only purchase.
A prescription decision
A licensed provider considers the person, the medicine and its risks. That review may end without a prescription. It also does not turn an unapproved medicine into an approved one.
04
The U.S. route, from question to review.
Promise prescribes semaglutide and tirzepatide now through licensed U.S. providers. A provider reviews every request and decides whether to prescribe. Not everyone qualifies.
A request for care
Promise offers visits for semaglutide and tirzepatide now. The request starts with health information, not a prescription.
A provider's decision
A licensed U.S. provider reviews every request and decides whether to prescribe. Not everyone qualifies.
A licensed pharmacy, if prescribed
If a provider prescribes, medications are prepared by licensed U.S. compounding pharmacies. Compounded medications are not FDA-approved. Availability varies by state and by treatment.
Promise is for U.S. patients only. Availability varies by state and by treatment.
Promise is LegitScript-certified. This is a private check of business standards, not FDA approval or a rating of medical care.
Promise has no retatrutide product. Its links here are for metabolic support, semaglutide or tirzepatide. They are not a route to retatrutide.
05
A few questions to start with.
What is the approval status of a compounded medicine?
Compounded medicines are not FDA-approved. Separate FDA-approved products containing semaglutide and tirzepatide exist.
Is this the NextGen Peptides store?
This is NextGen, a guide. There is no shop, checkout or medicine for sale here.
The next step starts with today's status.
Keep the trial question separate from the care question. Read about licensed options and their limits before drawing a conclusion from a compound's name.